369 related articles for article (PubMed ID: 29244650)
1. Pharmacotherapy for obesity: What you need to know.
Bersoux S; Byun TH; Chaliki SS; Poole KG
Cleve Clin J Med; 2017 Dec; 84(12):951-958. PubMed ID: 29244650
[TBL] [Abstract][Full Text] [Related]
2. Practical Use of Pharmacotherapy for Obesity.
Igel LI; Kumar RB; Saunders KH; Aronne LJ
Gastroenterology; 2017 May; 152(7):1765-1779. PubMed ID: 28192104
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic therapies for obesity.
Kaplan LM
Gastroenterol Clin North Am; 2010 Mar; 39(1):69-79. PubMed ID: 20202580
[TBL] [Abstract][Full Text] [Related]
4. Current and emerging pharmacotherapies for obesity in Australia.
Hocking S; Dear A; Cowley MA
Obes Res Clin Pract; 2017; 11(5):501-521. PubMed ID: 28818558
[TBL] [Abstract][Full Text] [Related]
5. Obesity Pharmacotherapy.
Saunders KH; Umashanker D; Igel LI; Kumar RB; Aronne LJ
Med Clin North Am; 2018 Jan; 102(1):135-148. PubMed ID: 29156182
[TBL] [Abstract][Full Text] [Related]
6. Obesity Epidemic: Pharmaceutical Weight Loss.
Curry SA
R I Med J (2013); 2017 Mar; 100(2):18-20. PubMed ID: 28246654
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment of obesity in Europe: waiting for the arrival of the white blackbird.
Rubio MA
Endocrinol Nutr; 2014 Dec; 61(10):501-4. PubMed ID: 25434595
[No Abstract] [Full Text] [Related]
8. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis.
Khera R; Murad MH; Chandar AK; Dulai PS; Wang Z; Prokop LJ; Loomba R; Camilleri M; Singh S
JAMA; 2016 Jun; 315(22):2424-34. PubMed ID: 27299618
[TBL] [Abstract][Full Text] [Related]
9. Overview of new antiobesity drugs.
Hainer V
Expert Opin Pharmacother; 2014 Oct; 15(14):1975-8. PubMed ID: 25100293
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of New Pharmacological Agents for the Treatment of Obesity.
Nuffer W; Trujillo JM; Megyeri J
Ann Pharmacother; 2016 May; 50(5):376-88. PubMed ID: 26887340
[TBL] [Abstract][Full Text] [Related]
11. The pharmacological and surgical management of adults with obesity.
Ryan DH
J Fam Pract; 2014 Jul; 63(7 Suppl):S21-6. PubMed ID: 25198216
[No Abstract] [Full Text] [Related]
12. Drug treatment of obesity: current status and future prospects.
Kakkar AK; Dahiya N
Eur J Intern Med; 2015 Mar; 26(2):89-94. PubMed ID: 25634851
[TBL] [Abstract][Full Text] [Related]
13. Recent advancements in drug treatment of obesity.
Carter R; Mouralidarane A; Ray S; Soeda J; Oben J
Clin Med (Lond); 2012 Oct; 12(5):456-60. PubMed ID: 23101148
[TBL] [Abstract][Full Text] [Related]
14. Nonincretin drugs in later-stage development.
Zimmerman MP; Mehr SR
Am J Manag Care; 2014 Jan; 20(1 Spec No.):E2. PubMed ID: 25618226
[No Abstract] [Full Text] [Related]
15. Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?
Tak YJ; Lee SY
Curr Obes Rep; 2021 Mar; 10(1):14-30. PubMed ID: 33410104
[TBL] [Abstract][Full Text] [Related]
16. Lorcaserin, phentermine topiramate combination, and naltrexone bupropion combination for weight loss: the 15-min challenge to sort these agents out.
Citrome L
Int J Clin Pract; 2014 Dec; 68(12):1401-5. PubMed ID: 25418525
[No Abstract] [Full Text] [Related]
17. Rationale for Utilization of Obesity Pharmacotherapy in the Active Duty Population.
Nadolsky KZ
Mil Med; 2018 Mar; 183(3-4):45-50. PubMed ID: 29420770
[No Abstract] [Full Text] [Related]
18. Pharmacotherapy for obesity.
Lee PC; Dixon J
Aust Fam Physician; 2017; 46(7):472-477. PubMed ID: 28697290
[TBL] [Abstract][Full Text] [Related]
19. Horizons in the Pharmacotherapy of Obesity.
Arch JR
Curr Obes Rep; 2015 Dec; 4(4):451-9. PubMed ID: 26346394
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy for obesity in individuals with type 2 diabetes.
Chukir T; Shukla AP; Saunders KH; Aronne LJ
Expert Opin Pharmacother; 2018 Feb; 19(3):223-231. PubMed ID: 29376439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
